WHO ICTRP trial
Use of photoliasis and topical antioxidants in the treatment of actinic…
RBR-957zf2 · Registro Brasileiro de Ensaios Clinicos (ReBEC) · Recruiting
Key facts
| Trial ID | RBR-957zf2 |
|---|---|
| Public title | Use of photoliasis and topical antioxidants in the treatment of actinic keratosis and skin cancer field: a randomized controlled trial |
| Scientific title | Use of photoliasis and topical antioxidants in the treatment of actinic keratosis and skin cancer field: a randomized controlled trial |
| Primary sponsor | Faculdade de Medicina de Botucatu - UNESP |
| Secondary sponsors | Faculdade de Medicina de Botucatu - UNESP |
| Registry | Registro Brasileiro de Ensaios Clinicos (ReBEC) |
| Recruitment status | Recruiting |
| Study type | Intervention |
| Countries | Brazil |
| Conditions | actinic keratosis;L57.0 |
| Interventions | Included patients will be randomized to receive FPS 99 sunscreen treatment containing photoliase, to be used twice daily with topical application to both forearms and back of hands; or sunscreen with SPF 99, also to be used twice a day on… |
| Registration date | Jan 27, 2020 |
| Registry page | ensaiosclinicos.gov.br |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: